NCT04728191

Brief Summary

The purpose of the study is to investigate the effect of physiotherapeutical instructions on dysfunctional breathing in children and adolescents with or without asthma. Children and adolescents with dysfunctional breathing, are invited to participate in the intervention study. Participants are stratified by asthma diagnose status and randomized to physiotherapy or standard care. Participants are followed a year after the intervention, to compare the development in asthma control ( if asthma) and quality of life.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
140

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 21, 2021

Completed
7 days until next milestone

First Posted

Study publicly available on registry

January 28, 2021

Completed
13 days until next milestone

Study Start

First participant enrolled

February 10, 2021

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
Last Updated

March 10, 2023

Status Verified

March 1, 2023

Enrollment Period

3.8 years

First QC Date

January 21, 2021

Last Update Submit

March 9, 2023

Conditions

Keywords

Dysfunctional breathingAsthma in childrenAsthma in adolescentsPhysiotherapy

Outcome Measures

Primary Outcomes (2)

  • Change from baseline in Asthma Control Questionnaire ( ACQ5) at 6 months.

    ACQ5 contains 5 questions regarding asthma symptoms. Each question is scored between 0-6 points, where 0 represents very good asthma control and 6 represents poor asthma control. Total ACQ score is calculates as an average of points. ACQ5 is taken by participants with asthma, at visits in the outpatient clinic.

    ACQ is taken at baseline and 6 months after intervention as primary outcome.

  • Change from baseline in Pediatric Quality of Life Inventory ( PedsQl) at 6 months

    PedsQl consists of 23 questions in 4 segments ( physical functioning, emotions, social interaction, and school activities). Each question is scored from 0 (best) to 4 (worst). The PedsQl questionnairre exists in formats for young children ( not used here), children aged 8-12 years and Teenagers aged 13-18 years. Children and adolescents are answering the age relevant questionnairre at visits in the out patient clinic. The PedsQl score is transformed to a 0-100 scale as follows: 0 =100, 1=75, 2=50, 3=25, 4=0. Health related Quality of life is calculated as a mean of scores. Psychosocial Health summary score is calculated as a mean of scores in the emotional, social and school functioning scales. Physical Health summary score is calculated as physical functioning scale score mean.

    PedsQL is taken at baseline and 6 months after intervention as primary outcome.

Secondary Outcomes (6)

  • Change from baseline in Nijmegen Questionnaire ( NQ)

    NQ is taken at baseline and 6 weeks, 6 months and 12 months after intervention.

  • Change from baseline in Brompton breathing Pattern Assesment Tool ( BBPAT)

    BBPAT is taken at baseline and 6 weeks, 6 months and 12 months after intervention.

  • Number of contacts to the hospital during one year from baseline

    from baseline to 12 months after intervention.

  • Change from baseline in Asthma Control Questionnaire ( ACQ5) at 6 weeks and one year. Change from 6 months in ACQ at 12 months.

    ACQ5 is taken at 6 weeks and 12 months after intervention as secondary outcomes.

  • Change from baseline in Pediatric Quality of Life Inventory ( PedsQl) at at 6 weeks and one year. Change from 6 months in PedsQl at 12 months.

    PedsQl is taken at 6 weeks and 12 months after intervention as secondary outcomes.

  • +1 more secondary outcomes

Study Arms (4)

+ asthma + intervention

EXPERIMENTAL

35 participants with asthma aged 10-17 years, randomized to physiotherapy. The intervention consists of 4 instruction lessons spread over 6 weeks. The participants are instructed in a daily ten-minute-program of breathing exercizes.

Other: Physiotherapy

+ asthma - intervention

ACTIVE COMPARATOR

35 participants with asthma aged 10-17 years, randomized to standard care. Participants are getting advice about dysfunctional breathing by a physician or nurse in the outpatient clinic.

Other: standard care

- asthma + intervention

EXPERIMENTAL

35 participants without asthma aged 10-17 years, randomized to physiotherapy. The intervention consists of 4 instruction lessons spread over 6 weeks. The participants are instructed in a daily ten-minute-program of breathing exercizes.

Other: Physiotherapy

- asthma - intervention

ACTIVE COMPARATOR

35 participants without asthma, which are randomized to standard care. Participants are getting advise about dysfunctional breathing by a physician or nurse in the outpatient clinic.

Other: standard care

Interventions

physiotherapeutical instructions and training as described.

+ asthma + intervention- asthma + intervention

Standard care as described.

+ asthma - intervention- asthma - intervention

Eligibility Criteria

Age10 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Asthma group:
  • Asthma diagnosed by lung function tests and/or typical symptoms.
  • Treatment with inhaled corticosteroids in minimum 3 months.
  • ACQ5 \>= 1.5.
  • NQ \>= 23.
  • NonAsthma group
  • Asthma denied after lung function tests ( exercise challenge or mannitol challenge)
  • NQ \>= 23.

You may not qualify if:

  • Other significant cardiopulmonary or muscoluskeletal conditions.
  • Complex functional conditions involving other organ systems.
  • patients who already had the physotherapeutical intervention before study start.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Signe Vahlkvist

Kolding, 6000, Denmark

RECRUITING

MeSH Terms

Conditions

Asthma

Interventions

Physical Therapy ModalitiesStandard of Care

Condition Hierarchy (Ancestors)

Bronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System Diseases

Intervention Hierarchy (Ancestors)

TherapeuticsRehabilitationQuality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Officials

  • Signe Vahlkvist, PhD

    Kolding Sygehus

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Signe Vahlkvist, PhD

CONTACT

Louise Jürgensen, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

January 21, 2021

First Posted

January 28, 2021

Study Start

February 10, 2021

Primary Completion

December 1, 2024

Study Completion

December 1, 2024

Last Updated

March 10, 2023

Record last verified: 2023-03

Data Sharing

IPD Sharing
Will share

Individual participant data that underlie published results, after deidentification.

Shared Documents
SAP
Time Frame
Beginning 3 months and ending 5 years following article publication.
Access Criteria
Researchers who provide a methodologically sound proposal. Proposals should be directed to Open@rsyd.dk.
More information

Locations